They’re used to help prevent nutrient deficiencies, maintain general health and support immune, bone and metabolic health. Now, new study findings published in Nature Medicine suggest there’s another ...

Black adults in Canada are more likely not to fill prescriptions because of financial constraints than white adults, ...

Mid-size companies investing in women's leadership report stronger revenue growth and talent retention, even as overall ...

The Pittsburgh Study launched in 2018 with philanthropic backing and has since attracted substantial government research ...

Sumter School District is being highlighted in a national case study examining how school systems can thoughtfully implement ...

A new study says the early U.S. COVID-19 death toll is much higher than official counts, and that there were disparities in ...

German auto industry exports to China plunged by a third last year as the country's manufacturers face fierce local ...

Meanwhile, the DOJ is trying to dismiss a case challenging its broken promises to trans military members.

One of Eli Lilly & Co.’s most highly anticipated experimental medicines helped diabetic patients lose more weight than any drug currently on the market, underscoring its potential in the increasingly ...

The companies developing new weight-loss medicines have a problem: the balance of power has shifted, and patients are bailing out of their clinical trials.

Some programs, though, have been studied a bit more rigorously than the standard pre-test, post-test maneuver.

The post Why Your AI Girlfriend is a Privacy Time Bomb: 150M Users at Risk appeared first on Android Headlines.